Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Diamond

Showing results (551-560 of 562) with videos related to

Pageof 57
Sort By:
Journal of Biomedical Informatics|September 11, 2025
Comparing clinical decision support systems for improving follow-up of abnormal cervical cancer screening test resultsSteven J Atlas, Timothy E Burdick, Adam Wright, et al.
Nature Communications|December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Annals of Internal Medicine|February 11, 2020
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical TrialIbrahim Aldoss, Corinna La Rosa, Lindsey R Baden, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
JCI Insight|July 7, 2017
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeysCody S Nelson, Diana Vera Cruz, Dollnovan Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmissionKristy M Bialas, Takayuki Tanaka, Dollnovan Tran, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
Contemporary Clinical Trials|August 10, 2021
Multilevel Follow-up of Cancer Screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test resultsJennifer S Haas, Steven J Atlas, Adam Wright, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 57

Showing results (551-560 of 562) with videos related to

Sort By:
Pageof 57
Journal of Biomedical Informatics|September 11, 2025
Comparing clinical decision support systems for improving follow-up of abnormal cervical cancer screening test resultsSteven J Atlas, Timothy E Burdick, Adam Wright, et al.
Nature Communications|December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Annals of Internal Medicine|February 11, 2020
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical TrialIbrahim Aldoss, Corinna La Rosa, Lindsey R Baden, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
JCI Insight|July 7, 2017
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeysCody S Nelson, Diana Vera Cruz, Dollnovan Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmissionKristy M Bialas, Takayuki Tanaka, Dollnovan Tran, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
Contemporary Clinical Trials|August 10, 2021
Multilevel Follow-up of Cancer Screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test resultsJennifer S Haas, Steven J Atlas, Adam Wright, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 57